AICAR peptide
AICAR peptide is a synthetic compound studied for its effects on cellular energy metabolism and metabolic signaling pathways. Although often discussed alongside metabolic peptides, AICAR is not a peptide, but a nucleoside analogue used in biochemical and metabolic research.
AICAR (5-aminoimidazole-4-carboxamide ribonucleotide) is known for its ability to activate AMP-activated protein kinase, an enzyme that plays a key role in regulating energy balance within cells.
Because AMPK acts as a central metabolic regulator, AICAR has been studied in research related to metabolism, exercise physiology, and cellular energy regulation.
Despite extensive experimental use, AICAR remains an investigational research compound and has not been widely approved as a pharmaceutical medication.
How AICAR peptide works
AICAR influences cellular metabolism primarily through its interaction with AMP-activated protein kinase (AMPK).
When inside cells, AICAR is converted into a molecule that mimics AMP (adenosine monophosphate), which activates AMPK signaling pathways. Activation of AMPK may lead to:
increased cellular energy production
stimulation of fatty acid oxidation
regulation of glucose metabolism
shifts in metabolic pathways toward energy conservation and efficiency
Because AMPK plays a central role in metabolic regulation, researchers often use AICAR as a tool to study processes related to exercise physiology, metabolic diseases, and cellular energy homeostasis.
Clinical trials and evidence
AICAR peptide has been widely used in biochemical and physiological research, particularly in studies examining AMPK signaling. Research has explored potential roles in areas such as:
metabolic regulation and energy balance
experimental models of metabolic diseases
studies of exercise adaptation and muscle metabolism
investigations of cellular responses to energy stress
Some experimental findings have shown that activation of AMPK can influence metabolic processes such as glucose uptake and fatty acid metabolism.
However, clinical development of AICAR as a pharmaceutical therapy has been limited, and most available data come from laboratory research and early-stage studies rather than large controlled clinical trials.
Possible side effects of AICAR peptide:
Because AICAR influences cellular metabolism and energy signaling pathways, potential side effects observed in experimental contexts may include:
headache
fatigue
mild gastrointestinal discomfort
changes in metabolic parameters
Since AICAR is primarily studied in research settings, its complete safety profile in humans has not been fully established.
Further clinical research is required to better understand the long-term safety and possible risks associated with this compound.